Drug intelligence / Profile preview

NCThera

Development stage: Preclinical
Lead developer: Flavocure Biotech
Modality: Nanoparticles → Drug Delivery Systems

Overview

NCThera is a proprietary theranostic nanoparticle platform developed by Flavocure in collaboration with Baylor College of Medicine. It is part of the broader NanoCaflanone™ Platform and is specifically engineered to deliver therapeutic payloads across the blood-brain barrier (BBB). The platform is described as configurable, allowing it to engage multiple molecular targets depending on the specific therapeutic application. NCThera is currently in preclinical development for the treatment of central nervous system (CNS) disorders and various oncology indications.

Brand names: NCThera
Other names: NanoCaflanone PlatformNanoCaflanone™ Platform

Targets

PTPN11 (Tyrosine-protein phosphatase non-receptor type 11)PIM2 (Proto-oncogene serine/threonine-protein kinase Pim2)CSF1R (Macrophage colony-stimulating factor receptor)FLT3 (Fms related receptor tyrosine kinase 3)CK2 (Casein kinase II subunit alpha)AURK (Aurora kinase)

Beyond the preview

Go deeper on NCThera.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NCThera.

Explore the full profile